## **Core Concept**
The question tests knowledge of glaucoma medications and their side effects, particularly in relation to urinary retention. Glaucoma is a condition characterized by increased intraocular pressure (IOP), and various classes of drugs are used to manage it. Some of these drugs can have systemic side effects due to their mechanism of action.

## **Why the Correct Answer is Right**
The correct answer, , is a muscarinic receptor agonist (or miotic). It works by increasing the outflow of aqueous humor from the eye, thereby reducing IOP. However, muscarinic agonists can also stimulate muscarinic receptors in the urinary bladder, enhancing bladder contractions and potentially worsening urinary retention.

## **Why Each Wrong Option is Incorrect**
* **Option A:** - This option is incorrect because is a prostaglandin analog, which works by increasing the uveoscleral outflow of aqueous humor. It does not have significant effects on the urinary system that would exacerbate urinary retention.
* **Option B:** - This option is incorrect because is a beta-blocker used in glaucoma to decrease aqueous humor production. Beta-blockers are not typically associated with urinary retention as a side effect.
* **Option D:** - This option is incorrect because is an alpha-2 adrenergic agonist. It decreases aqueous humor production and increases uveoscleral outflow. While it has systemic effects, exacerbating urinary retention is not a commonly associated side effect.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that patients with glaucoma who are also experiencing urinary retention should avoid medications that can worsen this condition, such as muscarinic receptor agonists. This is crucial because managing glaucoma often involves considering the patient's overall health and potential side effects of medications.

## **Correct Answer: .**